BPC-157 is one of the most commonly added peptides by men on TRT. Not because it affects testosterone — it does not — but because it addresses several things that long-term TRT can affect: gut integrity, connective tissue health and systemic inflammation.
BPC-157 (Body Protection Compound 157) is a 15-amino acid peptide isolated from human gastric juice with over 50 published animal studies. Its documented mechanisms include: promotion of angiogenesis at sites of tissue damage, upregulation of growth factor receptors, modulation of nitric oxide pathways to reduce inflammation, acceleration of tendon and ligament healing, and gut mucosal protection.
It can be administered systemically via SubQ injection or orally for gut-specific effects — one of the few peptides that is stable in gastric acid.
Long-term TRT affects gut microbiome composition and can increase intestinal permeability in some men. Some men on TRT report digestive symptoms that were not present before therapy.
BPC-157 is uniquely suited to gut health — stable in gastric acid, acting locally in the gastrointestinal tract when taken orally. Studies show significant protective effects against gut inflammation, ulceration and permeability. For men experiencing gut symptoms on TRT, oral BPC-157 is one of the more evidence-supported options.
Testosterone increases strength and muscle mass but does not proportionally increase tendon and ligament strength. This creates a situation where contractile force can exceed what connective tissue can safely absorb — a pattern associated with increased injury rates in men on testosterone.
BPC-157 tendon healing properties make it a logical companion. Regular use may support connective tissue integrity during heavy training on TRT and accelerate recovery from accumulated minor injuries.
BPC-157 modulation of the NO-VEGF pathway provides a systemic anti-inflammatory effect that some men find complements TRT well — particularly men who experience elevated inflammatory markers on certain protocols.
This is less studied than tissue repair effects, but the mechanism is understood and the safety profile supports its use in this context.
In TRT companion protocols, BPC-157 is used in cycles rather than continuously — 8-12 week courses with breaks. For gut health, oral BPC-157 daily for a defined course. For systemic and connective tissue effects, SubQ injection.
The full TRT companion protocol on the platform covers BPC-157 dosing, timing, cycling, blood work and what to monitor alongside standard TRT panels. Available to members.
We'll email you when we publish something new. Free, no account needed, unsubscribe anytime.
Full TRT blood work calendar, gonadorelin protocol and peptide companion guide — available to members.